Richard H. Chapman, PhD  |  Director

Dr. Chapman directs the programming and analysis of economic evaluations and health outcomes studies. His work focuses on the methodological quality of health economic analyses, and on patient-reported outcomes, including quality of life and patient preferences.
Dr. Chapman has also focused on the strategic communication of scientific information, and has published extensively in this regard, including articles on the appropriateness of using quality of life adjustments in cost-effectiveness analyses and what we know about the cost-effectiveness of pharmaceuticals in general.

Prior to joining ValueMedics Research, Dr. Chapman was a research associate at the Center for Risk Analysis at Harvard School of Public Health, while completing a doctoral degree in health policy. In this capacity, he helped to develop the CEA Registry, a comprehensive database of published cost-effectiveness analyses that has been used to study variability in the methods used to calculate cost-per-QALY measures. A summary of this project, along with comprehensive tables of published $/QALY ratios, is available on the Center for Risk Analysis Web site (http://www.hsph.harvard.edu/cearegistry/). Major focuses of Dr. Chapman’s research and publications have included the estimation of health-state preference (utility) weights by different populations, the determination of when quality-adjusting life-years is useful for cost-effectiveness analysis, and the effects of recommended standards on the conduct and reporting of cost-effectiveness analyses.

Dr. Chapman received his PhD degree in Health Policy (concentrating in Decision Sciences) from Harvard University. Prior to this, he earned his MS degree in Health Policy and Management from the Harvard School of Public Health, where he investigated the association between quality of care and health-care financing mechanisms. Before enrolling at the School of Public Health, he conducted research on the practice of transfusion medicine as part of a NHLBI Specialized Center of Research at the Center for Blood Research in Boston.